共 50 条
- [31] Effectiveness of quetiapine in patients with bipolar I and II depression: A multi-center, prospective, open-label, observational studyINTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 126 - 126Jeong, J. -H.Bahk, W. -M.Woo, Y. S.Seo, H. -J.Hong, S. -C.Jon, D. -I.Cho, H. -S.Yoo, S. Y.Min, K. J.Yoon, B. -H.
- [32] Rationale and Design of a Phase II Open-Label, Multicenter Study to Assess the Pharmacokinetics and Pharmacodynamics of Crizanlizumab in Adult Patients with Sickle Cell DiseaseBLOOD, 2017, 130Kanter, JulieElliott, BrianWeber, DenisTanaka, ChiakiXiang, FangAtaga, Kenneth I.
- [33] A single arm, open-label, phase II study to assess the efficacy of locitanib in patients with FGFR1-amplified surmounts NSCLC (sqNSCLC)JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Spigel, David R.Cereda, RobertaLitten, Jason B.Allen, Andrew R.Glaccone, GiuseppeSocinski, Mark A.Camidge, D. RossBesse, Benjamin
- [34] A multicenter open-label phase I/II study to assess the safety, tolerability, and efficacy of three dose levels of TuNEX in patients with rheumatoid arthritisJOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2011, 74 (12) : 544 - 551Chen, Der-YuanLai, Ning-ShengLu, Ling-YingChou, Hsiu-ChengChen, Yi-HsingHsieh, Tsu-YiChen, Yi-MingLan, Joung-Liang
- [35] Gaining Insight Into a Lack of Insight: Quantifying Anosognosia in an Open-Label Trial on the Effects of Increasing Cortical Dopamine on Cognitive and Behavioral Dysfunction in Patients With Traumatic Brain InjuryNEUROPSYCHOPHARMACOLOGY, 2016, 41 : S558 - S559Kvarta, MarkBerich, EmilyPostell, ElizabethMaclay, AlexanderJaffe, AndrewWeinberger, DanielLauterbach, MargoSchloesser, Robert
- [36] Long term effects of rivastigmine in patients with traumatic brain injury with cognitive deficits: Results of a 26-week open-label extension to a 12-week double-blind studyANNALS OF NEUROLOGY, 2006, 60 : S62 - S62Gunay, IbrahimKoumaras, BarbaraSilver, Jonathan
- [37] Osimertinib for patients with EGFR-mutant advanced NSCLC and asymptomatic brain metastases: An open-label, two-arm, phase II studyANNALS OF ONCOLOGY, 2019, 30Gillis, R.Peled, N.Goldshtien, I.Rotem, O.Rozenblum, A. B.Nechushtan, H.Chen, L.Dudnik, E.Zer, A.Yust-Katz, S.Shelef, I.Roisman, L. C.Inbar, E.
- [38] TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive gliomaNEURO-ONCOLOGY ADVANCES, 2024, 6 (01)Picca, AlbertoDi Stefano, Anna LuisaSavatovsky, JulienDucray, FrancoisChinot, OlivierMoyal, Elisabeth Cohen-JonathanAugereau, PauleLe Rhun, EmilieSchmitt, YohannRousseaux, NabilaYepnang, Ariane Murielle MbekweEstellat, CandiceCharbonneau, FrederiqueLetourneur, QuentinBranger, Dominique FigarellaMeyronet, DavidFardeau, ChristineMokhtari, KarimaBielle, FranckIavarone, AntonioSanson, Marc
- [39] A 52-Week, Multicenter, Prospective, Observational, Non-Interventional, Open-Label Study to Assess the Effectiveness, Safety and Tolerability of Everolimus in Kidney Transplant Patients in TaiwanAMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15Wang, S. -M.Lee, P. -C.Lian, J. -D.Shu, K. -H.Wu, S. -T.Chen, H. -C.Huang, C. -C.Wu, M. -S.Tian, Y. -C.Chiang, Y. -J.Chen, Y. -T.Wang, H. -P.
- [40] An open-label, single-arm, phase II trial of buparlisib in patients with melanoma brain metastases not eligible for surgery or radiosurgery-the BUMPER studyNEURO-ONCOLOGY ADVANCES, 2020, 2 (01)Amaral, TeresaNiessner, HeikeSinnberg, TobiasThomas, IoannisMeiwes, AndreasGarbe, ClausGarzarolli, MarleneRauschenberg, RicardaEigentler, ThomasMeier, Friedegund